Eisai Co. and Biogen Inc.’s Alzhiemer’s drug Leqembi has been granted full approval by the Food and Drug Administration, making it the first disease-slowing drug to secur...
The “nation’s doctor” is on a campaign to combat what he calls an epidemic of loneliness and isolation taking its toll on roughly half the people in the United States. Hi...
The ill-fated passengers who died trying to visit the wreck of the Titanic paid an extraordinary price for the privilege: $250,000 each. This is hardly surprising, given ...
The plot to bring liquid explosives onto flights from London to the U.S. and Canada in 2006 prompted the Transportation Security Administration to institute a limitation ...
As we celebrated the Fourth of July with hot dogs and fireworks, mourners gathered at Kyiv’s famous St. Michael’s Golden-Domed Cathedral. They were paying last respects ...
Richard Nixon and Spiro Agnew had never gotten along well. It likely didn’t pain the president much to acquiesce in the ousting of his vice president over illegal kickbac...
Although Gerald R. Ford was never elected as vice president or president and served for only two-and-a-half years, didn’t get the United States involved in many foreign a...
In May, Typhoon Mawar, the world’s strongest storm this year, was barreling toward the Philippines, where I live and work. Filipinos immediately began evacuating by the t...
America’s armed services are failing to meet their recruiting goals, with the Army in particular suffering the worst shortfalls in five decades. There are many reasons be...
New data from an experimental drug being developed by Eli Lilly & Co. raises an intriguing question about obesity treatments: How low can the weight loss go?
For a subset...